1.63
+0.03(+1.88%)
Currency In USD
| Previous Close | 1.6 |
| Open | 1.56 |
| Day High | 1.82 |
| Day Low | 1.56 |
| 52-Week High | 41.12 |
| 52-Week Low | 1.36 |
| Volume | 229,081 |
| Average Volume | 198,317 |
| Market Cap | 36.3M |
| PE | 0.57 |
| EPS | 2.88 |
| Moving Average 50 Days | 3.57 |
| Moving Average 200 Days | 8.31 |
| Change | 0.03 |
If you invested $1000 in Cyclacel Pharmaceuticals, Inc. (CYCC) 10 years ago, it would be worth $0.04 as of June 01, 2025 at a share price of $1.63. Whereas If you bought $1000 worth of Cyclacel Pharmaceuticals, Inc. (CYCC) shares 5 years ago, it would be worth $1.34 as of June 01, 2025 at a share price of $1.63.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
GlobeNewswire Inc.
May 07, 2025 1:00 PM GMT
BERKELEY HEIGHTS, NJ, May 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implem
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
GlobeNewswire Inc.
Mar 24, 2025 11:30 AM GMT
KUALA LUMPUR, Malaysia, March 24, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a s
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership
GlobeNewswire Inc.
Feb 27, 2025 6:38 PM GMT
BERKELEY HEIGHTS, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicines, today announced a change in control and lead